AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...
To be included on the World Heritage List, sites must be of outstanding universal value and meet at least one out of ten selection criteria. These criteria are explained in the Operational Guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback